Carol Gorman reflects on the problem of drug industry marketeers ghostwriting one-sided articles for peer-reviewed journals. How can we prevent and detect the distortions? After mentioning several other steps, she concludes:
...A final step toward eliminating hidden biases and restoring trust in medical literature is full disclosure of industry support and open access to clinical study data.
PS: In short, open data is not just to accelerate research and facilitate replication.
Posted by
Peter Suber at 4/16/2009 02:27:00 PM.
The open access movement:
Putting peer-reviewed scientific and scholarly literature
on the internet. Making it available free of charge and
free of most copyright and licensing restrictions.
Removing the barriers to serious research.
I recommend the OA tracking project (OATP) as the best way to stay on top of new OA developments. You can read the OATP feed on a blog-like web page or subscribe to it by RSS, email, or Twitter. You can also help build the feed by tagging new developments you encounter.
